A Multi-Center, Randomized, Placebo-Controlled, Double-B

Project: Research project

Project Details

Description

A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Lucassin (Terlipressin) (REVERSE Trial)
StatusFinished
Effective start/end date8/3/10 → 12/31/13

Funding

  • IKARIA THERAPEUTICS, LLC
View all
View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint